The Impact of Injection Location on the Efficacy of Intravesicular Onabotulinumtoxin A in Interstitial Cystitis--Phase 4
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Interstitial cystitis
- Focus Therapeutic Use
- 10 Dec 2015 Planned End Date changed from 1 Aug 2015 to 1 Aug 2017 as reported by CliniicalTrials.gov record.
- 10 Dec 2015 Planned primary completion date changed from 1 Aug 2015 to 1 Aug 2017 as reported by ClinicalTrials.gov record.
- 04 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.